Summary

Europe has an aging population, and sleep apnea becomes more prevalent with age. As the proportion of elderly individual’s increases, there is a corresponding rise in the number of people suffering from sleep apnea, driving the demand for therapeutic devices. The prevalence of sleep apnea has been on the rise, possibly due to lifestyle changes, obesity, and other factors. As more people are diagnosed with sleep apnea, the demand for therapeutic devices increases. There has been a growing awareness of sleep apnea and its potential health risks. Healthcare professionals and the general public have become more knowledgeable about the condition, leading to an increase in the number of diagnosed cases. The awareness of the association between sleep apnea and other health conditions, such as cardiovascular diseases, diabetes, and obesity, has grown. As healthcare professionals recognize the interconnectedness of these conditions, there is a greater emphasis on treating sleep apnea, contributing to the demand for therapeutic devices. Patients are becoming more proactive in managing their health. With easy access to information, individuals are educating themselves about sleep disorders and the available treatment options. This increased patient empowerment can drive the demand for sleep apnea therapeutic devices. Manufacturers are continuously working to enhance the design and comfort of sleep apnea devices to improve patient compliance. Innovations that address issues such as discomfort, noise, and portability can contribute to higher adherence to therapy, leading to overall market growth. Economic stability and disposable income levels in Europe can influence the affordability and adoption of sleep apnea therapeutic devices. A stable economic environment may lead to increased healthcare spending and investment in advanced medical technologies. Research funding for sleep disorders, including sleep apnea, can lead to the development of more advanced and effective therapeutic devices. Increased investment in research and development can drive innovation in the market.

According to the research report "Europe Sleep Apnea Therapeutic Devices Market Outlook, 2028," published by Bonafide Research, the Europe Sleep Apnea Therapeutic Devices market was valued more than USD 2 Billion in 2022. Sleep apnea is a common sleep disorder that affects millions of people around the world. It is characterized by pauses in breathing or shallow breathing during sleep. These pauses can last for several seconds or even minutes, and can occur dozens of times per night. The prevalence of sleep apnea varies from country to country, but it is estimated that around 175 million adults in Europe have sleep apnea. This represents approximately 44% of the adult population. There is a trend towards home sleep testing for the diagnosis of sleep apnea. Portable monitoring devices are gaining acceptance as they offer convenience and can be more cost-effective compared to in-laboratory sleep studies. This trend may influence the type of therapeutic devices prescribed. The demand for compact and portable sleep apnea devices is rising, especially among individuals who travel frequently. Portable devices offer greater flexibility and ease of use for individuals on the go, contributing to increased patient compliance. Device manufacturers are placing a greater emphasis on improving patient comfort. This involves designing masks that are less intrusive, reducing noise levels, and addressing common issues that can affect patient comfort during therapy. Wearable devices, including smartwatches and fitness trackers, are incorporating sleep health tracking features. This integration may lead to an early identification of sleep apnea symptoms, driving individuals to seek diagnosis and treatment with therapeutic devices. Collaborations between manufacturers of sleep apnea devices and sleep clinics or specialists can lead to more holistic and patient-centered care. Such partnerships may involve joint research initiatives, educational programs, and integrated care pathways.

In terms of country the market is divided into Germany, United Kingdom, France, Italy, Spain and Russia. Germany, like many other developed countries, has a relatively high prevalence of sleep apnea. A significant portion of the population is affected by sleep disorders, including obstructive sleep apnea. This high prevalence creates a substantial market for sleep apnea therapeutic devices. Germany is known for its advanced healthcare infrastructure and well-established medical facilities. The country has a robust healthcare system that facilitates the diagnosis and treatment of sleep disorders, including the provision of therapeutic devices. Germany is one of the largest economies in Europe, and its economic strength allows for investment in healthcare infrastructure and technology. The country's economic stability can positively impact the availability and adoption of advanced medical devices, including those for sleep apnea treatment. Furthermore, Economic development and increased healthcare spending can positively impact the sleep apnea therapeutic devices market. As the overall economy improves, individuals may have better access to healthcare services and be more willing to invest in sleep apnea treatment. According to the Italian Association of Sleep Medicine (AIMS), there are currently over 300 sleep labs or clinics in Italy. The number of sleep labs and clinics has been increasing in recent years due to the growing awareness of the importance of sleep and the increasing prevalence of sleep disorders.

Based on product market is bifurcated into Positive Airway Pressure (PAP) Device, Adaptive Servo-Ventilation (ASV), Airway Clearance Systems, Oxygen Devices, Oral Appliances and Others. PAP devices, including Continuous Positive Airway Pressure (CPAP) and Bi-level Positive Airway Pressure (BiPAP) machines, are highly effective in managing obstructive sleep apnea (OSA). They work by delivering a continuous or variable stream of air to keep the airways open, preventing episodes of apnea and hypopnea during sleep. PAP therapy has gained widespread acceptance among healthcare professionals as a standard and effective treatment for sleep apnea. Physicians often prescribe PAP devices as a first-line treatment for moderate to severe cases of obstructive sleep apnea. The market offers a variety of PAP devices, allowing healthcare providers to tailor treatment plans to individual patient needs. CPAP, BiPAP, and AutoPAP (Auto-adjusting Positive Airway Pressure) devices provide options that can be adapted based on the severity and characteristics of sleep apnea. The PAP device segment continually experiences technological advancements. Innovations in device design, mask technologies, and data connectivity contribute to improved user experience, making these devices more user-friendly and efficient. Clinical guidelines and recommendations from healthcare organizations often highlight the effectiveness of PAP therapy in managing sleep apnea. Consistent endorsement by medical professionals reinforces the role of PAP devices as a primary treatment option.

In terms of end user segment market is segmented into Home care Settings & Individuals and Sleep laboratories & Hospitals. Sleep laboratories play a crucial role in the diagnosis of sleep apnea. These facilities are equipped with specialized equipment to conduct comprehensive sleep studies, including polysomnography (PSG) and home sleep testing, which are essential for accurate diagnosis and severity assessment of sleep apnea. Growing awareness of sleep disorders, including sleep apnea, has led to an increase in the number of individuals seeking diagnosis and treatment. Sleep laboratories, being specialized facilities, are at the forefront of diagnosing sleep-related issues, contributing to the overall growth of this segment. Sleep laboratories often offer home sleep testing services, enabling individuals to undergo sleep studies in the comfort of their homes. The convenience and accessibility of home sleep testing contribute to the popularity of sleep laboratories as a diagnostic option. Hospitals, as major healthcare institutions, often serve as the initial point of contact for individuals seeking treatment for sleep apnea. The close association between sleep laboratories and hospitals facilitates the transition from diagnosis to treatment initiation, promoting a comprehensive and coordinated healthcare approach. Sleep laboratories and hospitals often adopt a multidisciplinary approach to the management of sleep disorders. This involves collaboration between pulmonologists, sleep medicine specialists, neurologists, and other healthcare professionals, ensuring a comprehensive and holistic treatment plan for individuals with sleep apnea.

Companies Covered in this report:

ResMed Inc. , Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., GE HealthCare Technologies, Inc., Invacare Corporation , Itamar Medical Ltd, Compumedics Ltd, Drive DeVilbiss Healthcare, Nihon Kohden Corporation.

Considered in this report

• Geography: Europe
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report

• Europe Sleep Apnea Therapeutic Devices market Outlook with its value and forecast along with its segments
• Country-wise Sleep Apnea Therapeutic Devices market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Country covered in the report:

• Germany
• United Kingdom
• France
• Italy
• Spain
• Russia

By Product

• Positive Airway Pressure (PAP) Device
• Adaptive Servo-Ventilation (ASV)
• Airway Clearance Systems
• Oxygen Devices
• Oral Appliances
• Others (Nasal dilators, Positional therapy, Surgical procedures, Electrical stimulation devices)

By End User

• Home care Settings & Individuals
• Sleep laboratories & Hospitals

The approach of the report:

This report consists of a combined approach of primary and secondary research. Initially, secondary research was used to get an understanding of the market and list the companies that are present in it. The secondary research consists of third-party sources such as press releases, annual reports of companies, and government-generated reports and databases. After gathering the data from secondary sources, primary research was conducted by conducting telephone interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this; we have started making primary calls to consumers by equally segmenting them in regional aspects, tier aspects, age group, and gender. Once we have primary data with us, we can start verifying the details obtained from secondary sources.

Intended audience

This report can be useful to industry consultants, manufacturers, suppliers, associations, and organisations related to the Sleep Apnea Therapeutic Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing and presentations, it will also increase competitive knowledge about the industry.






***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents